February 11, 2025, 03:39 AM ET, BY Momei, Contributor, Stock Traders Daily | Editor: Derek Curry ( Follow on LinkedIn ) ...

BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

BMO Capital Markets adjusted its outlook on Digital Realty Trust (NYSE:DLR) shares, reducing the price target to $200 from the previous $205, while maintaining an Outperform rating on the stock. With ...

February 10, 2025, 06:06 AM ET, BY Jake B., Contributor | Editor: Derek Curry ( Follow on LinkedIn ) ...

The products are subject to final approval by Cboe Canada. Once they are listed on the exchange, BMO will become the second ...

President Donald Trump pulled back from the edge on Feb. 1, just hours before Canadian exports to the U.S. were to be hit ...

This includes optimizing investment portfolios, enhancing risk management solutions, and fostering overall client prosperity. BMO's Chief AI and Data Officer, Dr. Kristin Milchanowski, emphasized ...

Analysts at JP Morgan and BMO Capital Markets downgraded Air Products and Chemicals Inc (NYSE:APD) on concerns over earnings growth, currency headwinds, and management transition.

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond ...

BMO has joined the IBM Quantum Network, gaining access to IBM’s quantum infrastructure. This move enables the bank to develop ...

Tuesday, BMO Capital Markets maintained their Outperform rating on Axalta Coating Systems (NYSE:AXTA) with a steady price target of $51.00. BMO Capital analysts highlighted the company's potential ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.